Today: 22 June 2026
Browse Category

Stock Market 4 February 2026

Alphabet shares fell about 5.6%, continuing their decline from May highs as investors expressed concerns over AI-related costs, new share sales, and further management changes. Despite this, Citizens maintained its Market Outperform rating and a $515 price target. AMC reported strong attendance for Toy Story 5, with over 4.8 million viewers at AMC Theatres and Odeon Cinemas, but its shares edged down to $2.79. The S&P 500 and Dow rose, with the Dow gaining 214.78 points, while the Nasdaq declined due to losses in large-cap tech stocks outweighing gains in chip stocks. Brent crude dropped below $79 as U.S.-Iran talks progressed, but U.S. 10-year yields continued to rise. TSMC’s U.S.-listed shares outperformed tech and chip ETFs, with June sales seen as a key catalyst, though risks remain tied to AI capacity spending. Marathon Digital Holdings (MARA) surged 12.8%, outperforming bitcoin and peers, as bitcoin ETF flows remained soft and institutional demand weak. Apogee Therapeutics jumped 47% after AbbVie agreed to acquire it for $135.11 per share, adding a late-stage IL-13 antibody to AbbVie’s portfolio. SK Hynix’s market cap surpassed Samsung Electronics for the first time since 2000, driven by high-bandwidth memory demand in the AI supply chain. Netflix shares rose 0.5% ahead of its July 16 Q2 earnings, with investors focused on ads, pricing, and margins. Definium’s Phase 3 trial for DT120 met its primary endpoint in major depressive disorder, boosting its shares. CRH will acquire Arcosa for $150 per share, expanding its U.S. aggregates and energy transmission assets.
AMD stock price slides in premarket as forecast hints at softer quarter, spotlight stays on China chip sales

AMD stock price slides in premarket as forecast hints at softer quarter, spotlight stays on China chip sales

AMD shares fell 7.6% in premarket trading Wednesday after the company forecast a sequential revenue decline and projected first-quarter sales near $9.8 billion. The outlook included $100 million in MI308 AI chip sales to China, with management citing U.S. export controls as a key uncertainty. Data-center revenue rose 39% to $5.4 billion last quarter, but investors focused on AMD’s 55% adjusted gross margin versus Nvidia’s higher target.
4 February 2026
··
SSE PLC share price rises after Q3 update trims FY earnings view; Ofgem price control in focus

SSE PLC share price rises after Q3 update trims FY earnings view; Ofgem price control in focus

SSE Plc shares rose 1.3% after the company cut its full-year earnings forecast to 144-152p per share, citing mixed weather. The utility reported a 7% rise in renewables output and a 64% jump in networks investment to £1.8 billion over nine months. SSE is still considering Ofgem’s RIIO-T3 settlement ahead of a March 3 deadline. Another trading update is due April 2.
4 February 2026
··
Vodafone share price jumps nearly 3% in London as buyback clock ticks and Q3 update looms

Vodafone share price jumps nearly 3% in London as buyback clock ticks and Q3 update looms

Vodafone shares rose 2.7% to 114.45 pence in early London trading Wednesday, ahead of the company’s Q3 FY26 update and investor Q&A set for Thursday. Trading volume reached 13.2 million shares by 09:03 GMT. Vodacom, majority-owned by Vodafone, reported a 13% jump in quarterly service revenue, led by growth in Egypt and Congo. Vodafone’s ongoing share buyback program is due to end Feb. 4.
4 February 2026
·
Zurich’s £8bn Beazley bid jolts FTSE 100 to a fresh record as GSK rallies, AI fears hit data stocks

Zurich’s £8bn Beazley bid jolts FTSE 100 to a fresh record as GSK rallies, AI fears hit data stocks

Zurich Insurance has proposed to buy Beazley for up to 1,335 pence per share, valuing the deal at about £8 billion. Beazley’s board said it would support the offer if Zurich makes a firm bid by Feb. 16. Beazley shares rose 9% on the news. The FTSE 100 hit a new intraday high, with GSK up and Relx and LSEG under pressure from AI concerns.
4 February 2026
·····
Sage Group share price slips again: AI selloff hits SGE.L ahead of AGM

Sage Group share price slips again: AI selloff hits SGE.L ahead of AGM

Sage Group shares fell 3.9% to 837 pence in London by mid-morning Wednesday, extending losses amid concerns that AI automation could threaten software subscription revenues. The company reported a 10% rise in organic revenue to £674 million and continued its buyback program, purchasing nearly 2 million shares on Feb. 3. Sage’s annual general meeting is set for Thursday, with a final dividend of 14.40 pence up for approval.
4 February 2026
··
3i Group shares dip as GIC tops 5% stake — what investors watch next

3i Group shares dip as GIC tops 5% stake — what investors watch next

3i shares fell 0.25% in early London trading after a filing showed Singapore’s GIC crossed a 5% ownership threshold. The company last week issued 31.4 million new shares to GIC in a £1 billion deal for a larger stake in Dutch retailer Action. 3i reported diluted NAV at 3,017 pence per share as of December 31 and holds a 62.3% stake in Action valued at £22.4 billion.
4 February 2026
·
BAE Systems share price ticks up as Ukraine air-defence buy, $195m US Marines order and buyback hit tape

BAE Systems share price ticks up as Ukraine air-defence buy, $195m US Marines order and buyback hit tape

BAE Systems shares edged up 0.1% to 1,933.5 pence in London after new Ukraine and U.S. defense contracts. The company secured a $195 million U.S. Marine Corps order and will supply air defense systems to Ukraine via a Swedish-Danish deal. Over 1,200 BAE workers in northwest England began a strike Feb. 2 over pay. BAE repurchased 110,541 shares for cancellation on Feb. 3.
4 February 2026
·
Novo Nordisk stock hammered as Ozempic maker warns 2026 sales may fall up to 13%

Novo Nordisk stock hammered as Ozempic maker warns 2026 sales may fall up to 13%

Novo Nordisk warned adjusted sales and operating profit may fall 5% to 13% in 2026, citing U.S. price cuts and rising competition from Eli Lilly. Shares plunged 18% in early Copenhagen trading. CEO Mike Doustdar called the U.S. price reductions for Wegovy “painful.” Novo also flagged patent expiries and pressure from compounded GLP-1 drugs.
4 February 2026
···
GSK stock swings after earnings as new CEO Luke Miels sets softer 2026 outlook

GSK stock swings after earnings as new CEO Luke Miels sets softer 2026 outlook

GSK shares rose 1.4% Wednesday morning after new CEO Luke Miels issued a 2026 outlook projecting slower sales growth and warning of possible weakness in vaccines and general medicines. The company reported 2025 sales up 7% to £32.67 billion and forecast 2026 turnover growth of 3% to 5%. Investors remain focused on GSK’s ability to manage looming HIV patent expirations.
4 February 2026
···
National Grid share price rises in London as €650m green bond terms land, Ofgem decision in view

National Grid share price rises in London as €650m green bond terms land, Ofgem decision in view

National Grid shares rose 0.6% to 1,264 pence in early London trading after its UK transmission unit set final terms for a €650 million green bond maturing in 2034. The bond carries a 3.563% coupon and is part of the group’s €20 billion note programme. Investors are watching Ofgem’s consultation on network licence changes, with responses due by March 2.
4 February 2026
··
Lloyds share price jumps toward a fresh high as corporate banking push report lands

Lloyds share price jumps toward a fresh high as corporate banking push report lands

Lloyds shares rose 1.4% to 114.2 pence in early London trading, approaching a 52-week high, after reports of a planned expansion into corporate banking. Deutsche Bank raised its target price to 125 pence, keeping a buy rating, while Shore Capital downgraded Lloyds to sell. The bank bought back nearly 3 million shares on Tuesday. Lloyds recently posted a 12% rise in 2025 pre-tax profit to £6.7 billion.
4 February 2026
·
1 … 432 433 434 435 436 … 1,579

Stock Market Today

  • Large $254M Outflows in XLP ETF Impact MDLZ, MO, CL Stocks
    June 22, 2026, 12:08 PM EDT. The Consumer Staples Select Sector SPDR Fund (XLP) saw a significant $254.1 million outflow, marking a 1.8% drop in shares outstanding week-over-week. Despite the outflow, major components like Mondelez International (MDLZ) rose 0.3%, while Altria Group (MO) and Colgate-Palmolive (CL) each climbed about 1.5%. XLP trades at $83.04, between its 52-week low of $75.16 and high of $90.14. Investors monitor such ETF unit outflows since they trigger sales of underlying assets, influencing the market prices of holdings like MDLZ, MO, and CL.

Latest articles

Alphabet Faces Pressure as Google Stock Drops on $85 Billion Share Sale and AI Talent Outflows

Alphabet Faces Pressure as Google Stock Drops on $85 Billion Share Sale and AI Talent Outflows

22 June 2026
Alphabet shares plunged 5.6% to $347.53 as investors reacted to a $40 billion at-the-market stock sale set for Q3, leadership exits to OpenAI and Anthropic, and soaring AI infrastructure costs, despite strong Q1 revenue and Google Cloud growth; free cash flow dropped to $10.1 billion as Alphabet shifts to an asset-heavy model, raising concerns about dilution and capital spending.
Strategy Bitcoin Buy Draws Focus to Saylor’s Cash-Reserve Move as STRC Under Pressure

Strategy Bitcoin Buy Draws Focus to Saylor’s Cash-Reserve Move as STRC Under Pressure

22 June 2026
Strategy Inc sold $335.5 million in common stock—nearly ten times its $34.9 million bitcoin purchase—boosting cash reserves to $1.4 billion as investors focus on the struggling STRC preferred shares, which remain below par and could raise funding costs if not stabilized; both bitcoin buys and reserve growth were funded by common-stock sales, shifting attention to capital access over bitcoin accumulation.
AMC stock looks at dilution risk while ‘Toy Story 5’ helps box office

AMC stock looks at dilution risk while ‘Toy Story 5’ helps box office

22 June 2026
AMC shares dipped to $2.79 after Toy Story 5 drove its busiest U.S. weekend of 2026, with over 4.8 million moviegoers and record food-and-beverage revenue, but recent $150 million share sales and warnings of future dilution and volatility may weigh on investors despite a 24.12% stock surge last week.
Go toTop